The XprESS LoProfile allows ear, nose and throat (ENT) physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation.

Entellus Medical president and CEO Robert White said: "We are very excited to bring our XprESS LoProfile Multi-Sinus Dilation System to the European market to help improve the outcome of patients suffering from chronic and recurrent sinusitis.

"Entellus balloon sinus dilation technology has been available for use by ENT physicians in the US since 2010 and we believe it is well suited for expansion into Europe to treat appropriately indicated patients."

The company said that its balloon sinus dilation products, when used as a stand-alone therapy in multicenter, randomized and controlled trial, were found to be as effective as functional endoscopic sinus surgery (FESS).

Entellus will showcase the XprESS LoProfile at the Congress of European ORL-HNS in Prague, which will be held from 7 to 11 June.

The company develops and markets products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room.